1.The price of drugs such as insulin remains at the forefront of many healthcare and political debates.  Novo Nordisk recently announced a partnership with discount retailer WalMart and Sam’s Club to distribute their Novolog/NovoRapid insulin as Reli-On Novolog at prices that are 50-75% lower than the cash price for Novolog.  This month’s question:  What do you think will happen to the price of insulin, overall, in the next 12 months?

It will come down substantially, due mostly to government subsidies & new regulations.

It will come down a little bit, due mostly to market forces.

It won’t change.  Nothing ever changes when it comes to drug prices.

It will probably go up. Greed always seems to win out.

I don’t really care… my insurance covers the cost of my insulin.